DS

David I. Stirling

BS Bristol-Myers Squibb: 37 patents #72 of 3,969Top 2%
BI Biotheryx: 3 patents #12 of 24Top 50%
AN Anthrogenesis: 2 patents #25 of 53Top 50%
ND National Research Development: 2 patents #124 of 1,071Top 15%
CG Celanese Gmbh: 1 patents #216 of 478Top 50%
📍 Berkeley Heights, NJ: #29 of 1,035 inventorsTop 3%
🗺 New Jersey: #1,076 of 69,400 inventorsTop 2%
Overall (All Time): #63,285 of 4,157,543Top 2%
46
Patents All Time

Issued Patents All Time

Showing 1–25 of 46 patents

Patent #TitleCo-InventorsDate
10106491 Substituted biaryl alkyl amides Kyle W.H. Chan, Frank Mercurio 2018-10-23
9546131 Substituted biaryl alkyl amides Kyle W.H. Chan, Frank Mercurio 2017-01-17
8889411 Modulation of stem and progenitor cell differentiation, assays, and uses thereof Robert J. Hariri, Laure Moutouh-De Parseval, Kyle W.H. Chan 2014-11-18
8822527 Substituted biaryl alkyl amides Kyle W.H. Chan, Frank Mercurio 2014-09-02
8288415 Pharmaceutical compositions of 3-(4-amino-1-oxoisoindolin-2yl)-piperidine-2,6-dione George W. Muller, Roger Shen-Chu Chen 2012-10-16
8158653 Pharmaceutical compositions of 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-4-amino isoindoline George W. Muller, Roger Shen-Chu Chen 2012-04-17
7834033 Methods for treating cancer using 3-[1,3dioxo-4-benzamidoisoindolin-2-yl]-2,6-dioxo-5-hydroxypiperidine George W. Muller, Hon-Wah Man 2010-11-16
7709502 Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and 1-oxoisoindolines George W. Muller, Roger Shen-Chu Chen 2010-05-04
7629360 Methods for the treatment of cachexia and graft v. host disease George W. Muller, Roger Shen-Chu Chen 2009-12-08
7498171 Modulation of stem and progenitor cell differentiation, assays, and uses thereof Robert J. Hariri, Laure Moutouh-De Parseval, Kyle W.H. Chan 2009-03-03
7459466 Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and -1-oxoisoindolines and method of reducing TNFα levels George W. Muller, Roger Shen-Chu Chen 2008-12-02
7329761 Substituted imides George W. Muller, Mary Shire 2008-02-12
7119106 Pharmaceutical compositions of 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline George W. Muller, Roger Shen-Chu Chen 2006-10-10
7041680 (R) and (S) isomers of substituted 2-(2,6-dioxopiperidin-3-yl) phthalimides and 1-oxoisoindolines and methods of using the same George W. Muller, Roger Shen-Chu Chen 2006-05-09
7005438 Pharmaceutically active isoindoline derivatives George W. Muller, Hon-Wah Man 2006-02-28
6844359 Substituted imides George W. Muller, Mary Shire 2005-01-18
6762195 Pharmaceutically active isoindoline derivatives George W. Muller, Hon-Wah Man 2004-07-13
6555554 Isoindolines, method of use, and pharmaceutical compositions George W. Muller, Roger Shen-Chu Chen 2003-04-29
6476052 Isoindolines, method of use, and pharmaceutical compositions George W. Muller, Roger Shen-Chu Chen 2002-11-05
6458810 Pharmaceutically active isoindoline derivatives George W. Muller, Hon-Wah Man 2002-10-01
6429221 Substituted imides George W. Muller, Mary Shire 2002-08-06
6395754 Substituted 2-(2,6-dioxopiperidin-3-yl)- phthalimides and 1-oxoisoindolines and method of reducing TNF&agr; levels George W. Muller, Roger Shen-Chu Chen 2002-05-28
6380239 Substituted 1-oxo- and 1,3-dioxoisoindoline and method of reducing inflammatory cytokine levels George W. Muller 2002-04-30
6335349 Substituted 2(2,6-dioxopiperidin-3-yl)isoindolines George W. Muller, Roger Shen-Chu Chen 2002-01-01
6316471 Isoindolines, method of use, and pharmaceutical compositions George W. Muller, Roger Shen-Chu Chen 2001-11-13